Loading Events

« All Webinars

“Modern Management of Heparin-Induced Thrombocytopenia (HIT): Focus on Direct-Acting Oral Anticoagulants (DOACs)”

HealthTrust presents…“Modern Management of Heparin-Induced Thrombocytopenia (HIT): Focus on Direct-Acting Oral Anticoagulants (DOACs)”

Download the content.

Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand.

Heparin-induced thrombocytopenia is a medical emergency associated with an immune-mediated response to anticoagulation with heparin and low molecular weight heparin. Previous management of HIT in both the acute and chronic stages involved parental agents, such as argatroban or fondaparinux, followed by warfarin as the primary oral agent. However, warfarin comes with a myriad of complications including Rivaroxaban, holding a key place in therapy. This presentation will review the efficacy and benefits of utilizing DOACs in this disease state.

Learning Objectives for Pharmacists  |  At the end of this session, participants should be able to:

  1. Identify current guidelines for the management of heparin-induced thrombocytopenia (HIT) and recent changes from former recommendations
  2. Recall the efficacy of direct-acting oral anticoagulants (DOACs) in HIT and preferred agents
  3. Recognize patient populations that may benefit from DOAC therapy in HIT and those in which DOACs may not be optimal


Christian Hardrick, PharmD  |  PGY-1 Pharmacy Resident  |  Princeton Baptist Medical Center

Target Audience: Pharmacists & Physicians

CE Credit: Approved for Pharmacists

This program is approved for CPEs by the Accreditation Council for Pharmacy Education (ACPE). Attendees of this program may earn 1.0 CPE Contact Hours. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this activity is 0863-9999-23-024-L01-P. The activity is approved for 1 hour (.1 CEUs) of continuing education credit for pharmacists who attend the webinar and complete the online evaluation.

Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.